Advertisement

Topics

Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017

04:20 EDT 11 Jul 2017 | PR Newswire

LOVELAND, Colo., July 11, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) - (News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to announce its second quarter 2017 financial results in a press release to be issued on Monday, July 31, 2017 before the market opens. The Company plans to host a conference call to discuss the results at 9 a.m. MT / 11 a.m. ET on the same day, Monday, July 31, 2017.

To access the conference call:

From within the United States, please dial 1-888-539-3624
From outside of the United States, please dial 1-719-325-2468
Reference Conference ID: 9569010

The conference call will be webcast live from the Company's website on www.heska.com.

A telephonic replay of the conference call will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Monday, August 7, 2017.

To access the replay:

From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 9569010

The webcast will also be archived on www.heska.com for 90 days.

About Heska
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.

View original content:http://www.prnewswire.com/news-releases/heska-schedules-second-quarter-2017-financial-results-conference-call-for-july-31-2017-300485677.html

SOURCE Heska Corporation

NEXT ARTICLE

More From BioPortfolio on "Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017"

Quick Search
Advertisement
 

Relevant Topics

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...